Salvage high-dose chemotherapy in patients with germ cell tumors (Q57575131)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Salvage high-dose chemotherapy in patients with germ cell tumors: an Italian experience with 84 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

2

Ugo De Giorgi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

Giovanni Rosti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Giorgio Papiani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Loretta Sebastiani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Marzia Argnani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Giuseppe Monti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Patrizia Ferrante

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Giorgio Pizzocaro

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Maurizio Marangolo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

309-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

High-dose chemotherapy in germ-cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

High-dose chemotherapy in germ cell tumours: a large single centre experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Treatment-Associated Leukemia Following Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk nonseminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10672

7 January 2021

Identifiers

DOI

10.1002/CNCR.10672

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12124831%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference